LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

14.57 -4.46

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.31

Max

15.11

Belangrijke statistieken
By Trading Economics
Inkomsten	-217K -19M
Verkoop	86K 86K
EPS	-0.29
Winstmarge	-22,540.698
Werknemers	75
EBITDA	-228K -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+44.74% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	19.03
Vorige sluitingsprijs	14.57

Nieuwssentiment

By Acuity

43%

57%

166 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 dec 2025, 15:21 UTC

Winsten

Correction to Home Depot Outlook Headline on Dec. 9

23 dec 2025, 23:54 UTC

Marktinformatie

Gold Climbs Above $4,500/oz for First Time Amid Rising Geopolitical Tensions -- Market Talk

23 dec 2025, 23:40 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

23 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

23 dec 2025, 21:21 UTC

Acquisities, Fusies, Overnames

St Barbara to Use Deposit Toward A$370 Million Subscription to Buy 50% of Simberi Unit

23 dec 2025, 21:20 UTC

Acquisities, Fusies, Overnames

St Barbara to Hold Deposit in Escrow

23 dec 2025, 21:20 UTC

Acquisities, Fusies, Overnames

St Barbara: Deposit Represents Progress on Lingbao's Strategic Investment in Simberi Mine

23 dec 2025, 21:19 UTC

Acquisities, Fusies, Overnames

St Barbara Receives A$32 Million Deposit From Lingbao Gold

23 dec 2025, 21:13 UTC

Acquisities, Fusies, Overnames

ServiceNow Bets on Cybersecurity to Boost Growth -- Analysis

23 dec 2025, 20:16 UTC

Marktinformatie

Oil Futures Settle Higher on Geopolitical Tensions -- Market Talk

23 dec 2025, 20:14 UTC

Marktinformatie

U.S. Natural Gas Soars on Colder Weather Outlook -- Market Talk

23 dec 2025, 19:13 UTC

Winsten

Acquisities, Fusies, Overnames

Mergers and Acquisitions Soared This Year. 2026 Could Be Even Bigger. -- Barrons.com

23 dec 2025, 18:58 UTC

Marktinformatie

Gold Has Another Record-Setting Day -- Market Talk

23 dec 2025, 18:32 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 3 to 409 -- Market Talk

23 dec 2025, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

23 dec 2025, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

23 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

23 dec 2025, 17:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Armis Seen as Good Fit for ServiceNow in $7.8B Deal -- Market Talk

23 dec 2025, 16:21 UTC

Marktinformatie

Monthly Canadian GDP Points to Flat Activity So Far for 4Q -- Market Talk

23 dec 2025, 16:16 UTC

Marktinformatie

Recent 'Disorderly' Yen Falls Could Justify Intervention -- Market Talk

23 dec 2025, 16:15 UTC

Marktinformatie

Precious Metals Pare Gains -- Market Talk

23 dec 2025, 16:03 UTC

Acquisities, Fusies, Overnames

Erste Group Bank: Closing Expected Around Mid-January

23 dec 2025, 16:03 UTC

Acquisities, Fusies, Overnames

Erste Group Bank Also Obtained Regulatory Approvals for 50% Stake in Santander Towarzystwo Funduszy Inwestycyjnych

23 dec 2025, 16:02 UTC

Acquisities, Fusies, Overnames

Erste Group Bank Obtained Regulatory Approvals by Polish Regulator KNF for Acquisition of Roughly 49% Controlling Stake in Santander Bank Polska

23 dec 2025, 16:01 UTC

Acquisities, Fusies, Overnames

Erste Group Bank Receives Green Light for Acquisition in Poland

23 dec 2025, 15:42 UTC

Acquisities, Fusies, Overnames

Telefonica: Agreement is For Sale of Telefonica Tech Business in Colombia, Mexico, Chile

23 dec 2025, 15:42 UTC

Acquisities, Fusies, Overnames

Telefonica Doesn't Set Out Financial Details of Divestment

23 dec 2025, 15:41 UTC

Acquisities, Fusies, Overnames

Telefonica: Deal Will Allow Focus on Core Markets

23 dec 2025, 15:40 UTC

Acquisities, Fusies, Overnames

Telefonica To Sell Telefonica Tech South American Business to Hiberus

23 dec 2025, 15:19 UTC

Marktinformatie

Fixed-Income Traders Misread Underlying Strength of Canada Economy -- Market Talk

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

44.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD 44.74%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

166 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.